Keywords: virazole, launch, luxembourg, spi, pharmaceuticals, been, granted

VIRAZOLE LAUNCH IN LUXEMBOURG

Article | 15 March 1993

Print This

- SPI Pharmaceuticals has been granted marketing approval in Luxembourg for an aerosol form of Virazole (tribavirin), to treat inluenza A ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in